At ESMO 2014, Prof Charles Swanton (London Research Institute and UCL, London, UK) discusses how we can begin to anticipate tumour evolutionary trajectories for a more proactive approach in clinical practice.
Join our mailing list
To receive the EMJ updates straight to your inbox free of charge, please click the button below.
Join Now